Archive · 3 Oct 2025
Doctors Warn Against Delaying Newborn Hepatitis B Vaccine
The hepatitis B vaccine is a shot given to babies soon after birth.
It protects against a serious liver infection called hepatitis B, which can lead to liver damage and cancer, especially in children.
Doctors strongly advise against delaying this vaccine, as even a short delay could lead to more children getting the disease.
The virus spreads through blood and body fluids, even from everyday things like sharing a toothbrush.
Contracting hepatitis B as a baby is much more dangerous than getting it as an adult.
The vaccine is safe and effective, and delaying it offers no benefit.
The hepatitis B vaccine is the first shot most U.S. babies receive.
Doctors warn delaying the vaccine could lead to more childhood cases of hepatitis B.
Hepatitis B is a serious liver infection that can lead to scarring, failure and cancer.
The virus spreads through blood and other bodily fluids and can live on surfaces.
Getting hepatitis B as a baby leads to a much higher risk of liver disease or cancer.
- Who
- Doctors, babies, and the Trump administration.
- What
- The hepatitis B vaccine, which doctors are concerned could be delayed, impacting newborn care.
- When
- The hepatitis B vaccine was licensed in the U.S. in 1981.
- Where
- United States.
- Why
- To prevent hepatitis B infection, which can cause liver disease and cancer.
Medical Professionals & Public Health Experts
POTUS Administration (Implied)
Vaccine Delay
Medical Professionals & Public Health Experts
Delaying the vaccine would lead to more infections and deaths.
POTUS Administration (Implied)
Considering a delay.
- Vaccine Licensed (U.S.)
- 1981
- First Dose Timing
- Birth
- Transmission Method
- Blood/Body Fluids
- Chronic Infection Risk (Infants)
- 90%
- Chronic Infection Risk (Adults)
- 5%
- Risk of Contracting if Household Member Has It
- 30%-50%